Russia's Gamaleya Research Institute has applied for an emergency use authorization (EUA) for Sputnik Light, a single-dose vaccine, the Food and Drug Administration (FDA) said on Monday night.
In the President's prerecorded "Talk to the People," FDA Director General Eric Domingo said the vaccine was being studied by local experts.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.